📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Imcyse

1.1 - Company Overview

Imcyse Logo

Imcyse

Headquarter: Belgium
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of clinical-stage biopharmaceutical R&D, pioneering active specific immunotherapies to treat severe, chronic autoimmune diseases. Its technology platform locally targets immune cells involved in the destruction of diseased organs.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Imcyse

Protomer Logo

Protomer

HQ: United States Website
  • Description: Provider of pre-clinical biotechnology R&D focused on metabolic diseases, developing glucose-responsive insulin receptor agonist therapeutics and the Molecular Evolution of Peptide Sensors (MEPS) platform for creating therapeutic peptides and proteins with tunable, small-molecule-controlled activity.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Protomer company profile →
Medicore Logo

Medicore

HQ: United States Website
  • Description: Provider of blood collection and diabetic care products, manufacturing and distributing to hospitals and medical companies. Holds multiple contracts with hospital group purchasing organizations, with product line available through nearly all major medical device distributors.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Medicore company profile →
GI Dynamics Logo

GI Dynamics

HQ: United States Website
  • Description: Provider of endoscopically delivered medical devices for managing type 2 diabetes, obesity, and related metabolic diseases, including RESET, which creates a barrier in the small intestine to improve insulin resistance and glycemic control.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full GI Dynamics company profile →
Serodus Logo

Serodus

HQ: Norway Website
  • Description: Provider of Scandinavian drug development focused on unmet needs in diabetes and diabetic comorbidities. In-licenses early-stage candidates and partners after Phase II proof of clinical effect. Pipeline includes SER150, an anti-inflammatory targeting diabetic kidney disease via thromboxane synthase inhibition and receptor blockade, and SER140, an IL-1β receptor antagonist for diabetic kidney disease.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Serodus company profile →
Alantos Logo

Alantos

HQ: United States Website
  • Description: Provider of chemistry-driven biopharmaceutical discovery and development of small molecule drugs for osteoarthritis, inflammation, and type II diabetes; offerings include tissue remodeling pathways for rheumatoid arthritis and a dipeptidyl peptidase IV inhibitor.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Alantos company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Imcyse

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Imcyse

2.2 - Growth funds investing in similar companies to Imcyse

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Imcyse

4.2 - Public trading comparable groups for Imcyse

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Imcyse

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Imcyse

What does Imcyse do?

Imcyse is a provider of clinical-stage biopharmaceutical R&D, pioneering active specific immunotherapies to treat severe, chronic autoimmune diseases. Its technology platform locally targets immune cells involved in the destruction of diseased organs.

Who are Imcyse's competitors?

Imcyse's competitors and similar companies include Protomer, Medicore, GI Dynamics, Serodus, and Alantos.

Where is Imcyse headquartered?

Imcyse is headquartered in Belgium.

How many employees does Imcyse have?

Imcyse has 1,000 employees 🔒.

When was Imcyse founded?

Imcyse was founded in 2010 🔒.

What sector and industry vertical is Imcyse in?

Imcyse is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Imcyse

Who are the top strategic acquirers in Imcyse's sector and industry

Top strategic M&A buyers and acquirers in Imcyse's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Imcyse?

Top strategic M&A buyers groups and sectors for Imcyse include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Imcyse's sector and industry vertical

Which are the top PE firms investing in Imcyse's sector and industry vertical?

Top PE firms investing in Imcyse's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Imcyse's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Imcyse's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Imcyse's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Imcyse include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Imcyse's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Imcyse?

The key public trading comparables and valuation benchmarks for Imcyse include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Imcyse for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Imcyse with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Imcyse's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Imcyse with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Imcyse's' sector and industry vertical?

Access recent funding rounds and capital raises in Imcyse's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Imcyse